All problems

For UK HealthTech & MedTech companies

You have a product that works but no structured plan for how to take it to market in the UK

A good product with a weak GTM will always be outcompeted by a weaker product with a strong commercial motion. In UK healthcare, where procurement is complex and buyer relationships are long, the GTM strategy is the variable that determines whether a company scales or stalls.

Cost of Inaction

Enter your target accounts, contracts live today, average contract value, and achievable conversion rate. The calculator shows the annual revenue a structured UK GTM could unlock.

Estimated Annual Cost
£54,000
Range: £32,400£81,000
40
6
£45,000
18 %

How it breaks down

  • Current contracted revenue£270,000
  • Revenue at target penetration£324,000

Two minutes, no typing, and I read every one myself.

Paul, Solvable

From Paul

Tell me where that £54,000 is coming from, and I'll come back with the three things to fix first.

A few quick questions, about two minutes, and no typing. I read every one myself and reply with the three things costing you most and where I'd start. If it's useful, we talk. If not, you've still got a clear picture.

No obligation, no sales call unless you ask for one, and nothing automated lands in your inbox.

Paul, Solvable

I reply personally, usually the same day.
  • Different team members describe the GTM strategy differently
  • No clear primary channel for new customer acquisition
  • Commercial narrative leads with product features not buyer outcomes
  • Pipeline has activity but low conversion to signed contracts
  • sales cycle is long and unpredictable
  • marketing and sales activity misaligned
  • Strategic: growth is founder-dependent and not scalable

Frequently asked questions

Why does this problem persist?

GTM strategy in healthcare is genuinely harder than in other sectors. NHS procurement cycles are long, decision-making is distributed across clinical, operational, and financial stakeholders, and the relationship between pilot success and commercial rollout is not automatic. Most founders build their GTM by trial and error rather than from a structured framework.

This is exactly what I do with UK private practices. Answer the few questions above and I'll come back personally with where to start. Paul.

Related problems

Solvable.Health© 2026

This information is for educational purposes only and does not constitute professional advice.